Hakutulokset - Wassim Abida

Tarkenna hakua
  1. 1
    p53-Dependent and p53-Independent Activation of Autophagy by ARF

    p53-Dependent and p53-Independent Activation of Autophagy by ARF Tekijä Wassim Abida, Wei Gu

    Julkaistu 2008
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    FBXO11 Promotes the Neddylation of p53 and Inhibits Its Transcriptional Activity

    FBXO11 Promotes the Neddylation of p53 and Inhibits Its Transcriptional Activity Tekijä Wassim Abida, Anatoly Nikolaev, Wenhui Zhao, Wenzhu Zhang, Wei Gu

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Comparison of Magnetic Resonance Imaging-stratified Clinical Pathways and Systematic Transrectal Ultrasound-guided Biopsy Pathway for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials

    Comparison of Magnetic Resonance Imaging-stratified Clinical Pathways and Systematic Transrectal Ultrasound-guided Biopsy Pathway for the Detection of Clinically Significant Prosta... Tekijä Sungmin Woo, Chong Hyun Suh, James A. Eastham, Michael J. Zeléfsky, Michael J. Morris, Wassim Abida, Howard I. Scher, Robert Sidlow, Anton S. Becker, Andreas G. Wibmer, Hedvig Hricak, Hebert Alberto Vargas

    Julkaistu 2019
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer

    Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer Tekijä Neel Shah, Ping Wang, John Wongvipat, Wouter R. Karthaus, Wassim Abida, Joshua Armenia, Shira Rockowitz, Yotam Drier, B Bernstein, Henry W. Long, Matthew L. Freedman, Vivek Arora, Deyou Zheng, Charles L. Sawyers

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Preliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC): Updated analyses

    Preliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC): Updated an... Tekijä Wassim Abida, David Campbell, Akash Patnaik, Brieuc Sautois, Jeremy Shapiro, Nicholas J. Vogelzang, Alan H. Bryce, Ray McDermott, Francesco Ricci, Julie Rowe, Jie Zhang, Andrew D. Simmons, Darrin Despain, Matthew Dowson, Tony Golsorkhi, S. Chowdhury

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics

    Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics Tekijä Bastien Nguyen, José Maurício Mota, Subhiksha Nandakumar, Konrad H. Stopsack, Emily S. Weg, Dana E. Rathkopf, Michael J. Morris, Howard I. Scher, Philip W. Kantoff, Anuradha Gopalan, Dmitriy Zamarin, David B. Solit, Nikolaus Schultz, Wassim Abida

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death

    Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death Tekijä Haley Hieronymus, Rajmohan Murali, Amy L. Tin, Kamlesh K. Yadav, Wassim Abida, Henrik Møller, Daniel M. Berney, Howard I. Scher, Brett S. Carver, Peter T. Scardino, Nikolaus Schultz, Barry S. Taylor, Andrew J. Vickers, Jack Cuzick, Charles L. Sawyers

    Julkaistu 2018
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer

    A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Tekijä Rahul Aggarwal, Michael T. Schweizer, David M. Nanus, Allan J. Pantuck, Elisabeth I. Heath, Eric Campeau, Sarah Attwell, Karen Norek, Margo Snyder, Lisa Bauman, Sanjay Lakhotia, Felix Y. Feng, Eric J. Small, Wassim Abida, Joshi J. Alumkal

    Julkaistu 2020
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis

    ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis Tekijä Rohit Bose, Wouter R. Karthaus, Joshua Armenia, Wassim Abida, Phillip J. Iaquinta, Zeda Zhang, John Wongvipat, Elizabeth V. Wasmuth, Neel Shah, Patrick Sullivan, Michael G. Doran, Ping Wang, Anna Patruno, Yilin Zhao, Deyou Zheng, Nikolaus Schultz, Charles L. Sawyers

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations

    Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombinat... Tekijä Wassim Abida, Alan H. Bryce, Nicholas J. Vogelzang, R. J. Amato, Ivor Percent, Julia Shapiro, Ray McDermott, Arif Hussain, Akash Patnaik, Daniel P. Petrylak, Charles J. Ryan, T. Stanton, Jie Zhang, Andrew D. Simmons, Darrin Despain, Marnie Collins, T. Golsorskhi, Howard I. Scher, S. Chowdhury

    Julkaistu 2018
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Significance of <i>BRCA2</i> and <i>RB1</i> Co-loss in Aggressive Prostate Cancer Progression

    Significance of <i>BRCA2</i> and <i>RB1</i> Co-loss in Aggressive Prostate Cancer Progression Tekijä Goutam Chakraborty, Joshua Armenia, Ying Z. Mazzu, Subhiksha Nandakumar, Konrad H. Stopsack, Mohammad Atiq, Kazumasa Komura, Lina Jehane, Rahim Hirani, Kalyani Chadalavada, Yuki Yoshikawa, Nabeela Khan, Yu Chen, Wassim Abida, Lorelei A. Mucci, Gwo‐Shu Mary Lee, Gouri J. Nanjangud, Philip W. Kantoff

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer

    Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer Tekijä Konrad H. Stopsack, Subhiksha Nandakumar, Andreas G. Wibmer, Samuel Haywood, Emily S. Weg, Ethan Barnett, Chloe J. Kim, Emily Carbone, Samantha E. Vasselman, Bastien Nguyen, Melanie Hullings, Howard I. Scher, Michael J. Morris, David B. Solit, Nikolaus Schultz, Philip W. Kantoff, Wassim Abida

    Julkaistu 2020
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Regenerative potential of prostate luminal cells revealed by single-cell analysis

    Regenerative potential of prostate luminal cells revealed by single-cell analysis Tekijä Wouter R. Karthaus, Matan Hofree, Danielle Choi, Eliot Linton, Mesruh Turkekul, Alborz Bejnood, Brett F. Carver, Anuradha Gopalan, Wassim Abida, Vincent P. Laudone, Moshe Biton, Ojasvi Chaudhary, Tianhao Xu, Ignas Masilionis, Katia Manova, Linas Mažutis, Dana Pe’er, Aviv Regev, Charles L. Sawyers

    Julkaistu 2020
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene Alterations

    Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene Alterations Tekijä José Maurício Mota, Ethan Barnett, Jones T. Nauseef, Bastien Nguyen, Konrad H. Stopsack, Andreas G. Wibmer, Jessica Flynn, Glenn Heller, Daniel C. Danila, Dana E. Rathkopf, Susan F. Slovin, Philip W. Kantoff, Howard I. Scher, Michael J. Morris, Nikolaus Schultz, David B. Solit, Wassim Abida

    Julkaistu 2020
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib

    Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib Tekijä Andrea Loehr, Arif Hussain, Akash Patnaik, Alan H. Bryce, Daniel Castellano, Albert Font, Jeremy Shapiro, Jingsong Zhang, Brieuc Sautois, Nicholas J. Vogelzang, Gurkamal Chatta, Kevin D. Courtney, Andrea Harzstark, Francesco Ricci, Darrin Despain, Simon P. Watkins, Charmin King, Minh Nguyen, Andrew D. Simmons, Simon Chowdhury, Wassim Abida

    Julkaistu 2022
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms

    Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms Tekijä Hanna Tukachinsky, Russell W. Madison, Jon Chung, Ole Gjoerup, Eric A. Severson, Lucas Dennis, Bernard J. Fendler, Samantha Morley, Lei Zhong, Ryon P. Graf, Jeffrey S. Ross, Brian M. Alexander, Wassim Abida, Simon Chowdhury, Charles J. Ryan, Karim Fizazi, Tony Golsorkhi, Simon P. Watkins, Andrew D. Simmons, Andrea Loehr, Jeffrey M. Venstrom, Geoffrey R. Oxnard

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy

    Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy Tekijä Charlotte S. Walmsley, Philip Jonsson, Michael L. Cheng, Sean M. McBride, Christopher Kaeser, H. Alberto Vargas, Vincent P. Laudone, Barry S. Taylor, Rajya Kappagantula, Priscilla Baez, Allison L. Richards, Anne Marie Noronha, D. S. Perera, Michael F. Berger, David B. Solit, Christine A. Iacobuzio‐Donahue, Howard I. Scher, Mark T.A. Donoghue, Wassim Abida, Alison M. Schram

    Julkaistu 2024
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    <i>SOX2</i> promotes lineage plasticity and antiandrogen resistance in <i>TP53</i> - and <i>RB1</i> -deficient prostate cancer

    <i>SOX2</i> promotes lineage plasticity and antiandrogen resistance in <i>TP53</i> - and <i>RB1</i> -deficient prostate cancer Tekijä Ping Mu, Zeda Zhang, Matteo Benelli, Wouter R. Karthaus, Elizabeth Hoover, Chi-Chao Chen, John Wongvipat, Sheng‐Yu Ku, Dong Gao, Zhen Cao, Neel Shah, Elizabeth Adams, Wassim Abida, Philip A. Watson, Davide Prandi, Chun‐Hao Huang, Elisa de Stanchina, Scott W. Lowe, Leigh Ellis, Himisha Beltran, Mark A. Rubin, David W. Goodrich, Francesca Demichelis, Charles L. Sawyers

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors

    Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors Tekijä Konrad H. Stopsack, Subhiksha Nandakumar, Kanika Arora, Bastien Nguyen, Samantha E. Vasselman, Barbara Nweji, Sean M. McBride, Michael J. Morris, Dana E. Rathkopf, Susan F. Slovin, Daniel C. Danila, Karen A. Autio, Howard I. Scher, Lorelei A. Mucci, David B. Solit, Mithat Gönen, Yu Chen, Michael F. Berger, Nikolaus Schultz, Wassim Abida, Philip W. Kantoff

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study

    Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Stud... Tekijä Wassim Abida, David Campbell, Akash Patnaik, Jeremy Shapiro, Brieuc Sautois, Nicholas J. Vogelzang, Éric Voog, Alan H. Bryce, Ray McDermott, Francesco Ricci, Julie Rowe, Jingsong Zhang, Josep M. Piulats, Karim Fizazi, Axel S. Merseburger, Celestia S. Higano, Laurence E. Krieger, Charles J. Ryan, Felix Y. Feng, Andrew D. Simmons, Andrea Loehr, Darrin Despain, Melanie Dowson, Foad Green, Simon P. Watkins, Tony Golsorkhi, Simon Chowdhury

    Julkaistu 2020
    Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: